MoneyWorks4Me

Sandu Pharmaceuticals informs about disclosure

18 Jul 2022 Evaluate

Sandu Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanbro Marketing Services.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1738.10
Dr. Reddys Labs. 1228.35
Cipla 1304.85
Lupin 1912.85
Zydus Lifesciences 1108.15
View more..